search
Back to results

Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth

Primary Purpose

Diabetes Mellitus, Type 2, Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Lifestyle Modification for Type 2 Diabetes Prevention
Nutrition and Physical Activity
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2

Eligibility Criteria

4 Years - 8 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 4-8 years old
  • Age- and sex-specific BMI ≥95th percentile

Exclusion Criteria:

  • Children with serious medical conditions
  • Children who show signs of elevated psychopathology, as assessed by the Child Behavior Checklist (CBCL)
  • Children of parents with significantly elevated psychiatric disorders

Sites / Locations

  • University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Other

Arm Label

Lifestyle Modification for Diabetes Prevention

Nutrition and Physical Activity

Arm Description

Family based intervention utilizing Traffic Light Diet, self monitoring, parent behavioral skill training and tool kit of items promoting physical activity.

Family based intervention providing education on healthy eating and physical activity but no behavioral skills training, goal setting, self monitoring or physical activity toolkit.

Outcomes

Primary Outcome Measures

Body Mass Index (BMI)
Change in BMI will be measured from baseline to end of intervention (6 months) and and also from 6 months to 12 months.
BMI-z score
Change in BMI-z score will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months.
Percent overweight (% overweight)
Change in percent overweight will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months. Percent overweight is computed as a child's actual BMI minus the median BMI for a child of comparable sex and age, divided by 100.
Waist Circumference(cm)
Change in waist circumference (cm) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Systolic Blood Pressure
Change in systolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Diastolic Blood Pressure (mm Hg)
Change in diastolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Pulse
Change in resting pulse will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Physical Activity
Change in physical activity was measured from baseline to end of treatment (6 months) and from end of treatment to 12 months using an accelerometer. The accelerometer measured light, moderate and moderate-to-vigorous actity over 7 days.
Glucose
Change in blood glucose levels were measured at baseline, 6 and 12 months.
Insulin
Change in plasma insulin levels from baseline to end of treatment (6 months) and from 6 months to 12 months.
Change in HDL, LDL, Total Cholesterol and Triglycerides
Change in lipid profile measures from baseline to end of treatment (6 months) and from 6 months to 12 months.
Change in Dietary Intake
Change in energy (kcals/day), protein, carbohydrate, fat, cholesterol, saturated fat and fiber intake.

Secondary Outcome Measures

Change in Parent BMI
Change in parent BMI from baseline to end of treatment (6 months) and from 6 motnths to 12 months.

Full Information

First Posted
May 30, 2012
Last Updated
May 31, 2012
Sponsor
University of Pennsylvania
Collaborators
American Diabetes Association
search

1. Study Identification

Unique Protocol Identification Number
NCT01610219
Brief Title
Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth
Official Title
Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth
Study Type
Interventional

2. Study Status

Record Verification Date
May 2012
Overall Recruitment Status
Completed
Study Start Date
August 2008 (undefined)
Primary Completion Date
January 2011 (Actual)
Study Completion Date
January 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania
Collaborators
American Diabetes Association

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The number of youth with Type 2 diabetes (T2D) is rising in the population, which is a concerning public health trend. There has been little research testing ways to prevent the development of this disease in children who are at increased risk to develop T2D. This study tests a family treatment program that treats 4-8 year old children who are at risk for T2D because they are overweight and have a family history of the disease. Sixty at risk children and their parents were assigned to one of 2 treatment conditions. Half of the families (randomly determined) received an intensive family treatment program that trains parents in how to increase healthier foods choices and physical activity for themselves and their children using "behavior modification" strategies. Children receiving this treatment were allowed to taste new fruits and vegetables used a pedometer to record how far they walked every day, and were given a "tool box" of toys and interactive games which promoted physical activity. The other half of the families only received instruction about healthier choices, but received no behavioral modification strategies or physical activity promotion tools. Improvements in children's body weight, blood measures, and behavior patterns were measured after treatment ended (6 months) and then again after 12 months. The results may lead to a better understanding of how family members can positively influence young children's behaviors to help prevent T2D. The objective of proposed study was to test a family-based intervention designed to reduce excess body weight, improve metabolic and cardiovascular profile, and improve diet and physical activity levels in 4 - 8 year old youth who are "at risk" for T2D. This intervention was tested in a 2-arm randomized controlled clinical trial. Primary Hypotheses: Compared to children receiving NPA, children receiving LMDP will show greater reductions in excess body weight, greater improvements in metabolic and cardiovascular measures, improved diet, increased physical activity, and reduced television viewing. Greater reductions in child excess body weight will be associated with greater improvements in metabolic and cardiovascular measures. Secondary Hypotheses: Compared to parents receiving the NPA intervention, parents receiving the LMDP intervention will show greater reductions in BMI. Greater improvements in parent BMI will be associated with greater improvements in child body composition, metabolic and cardiovascular measures, and behavioral outcomes. Compared to families receiving the NPA intervention, families receiving the LMDP intervention will show an increase in the number of fruits and vegetables and lower energy density foods stored at home.
Detailed Description
There is mounting concern about the development of Type 2 diabetes (T2D) in youth, especially in light of rising childhood obesity rates at younger ages. The health costs of T2D are notable both for the individual and society, and so interventions that can help prevent the development of T2D in early life are needed. Fortunately, there is promising evidence from the Diabetes Prevention Program (DPP) and other randomized trials with adults that the onset of T2D can be prevented through sustainable lifestyle changes. However, intervention programs have not been tested in young children who are "at risk" for developing the disease, even though this may be a critical period for obesity onset and for the formation of early eating and physical activity habits. The primary aim of the proposed study was to test a family-based intervention that targets improvements in excess weight gain, metabolic and cardiovascular profile, and diet and physical activity in 4 - 8 year old children who are "at risk" for T2D. Specifically, 60 families were randomized either to one of two treatments: Lifestyle Modification for Diabetes Prevention (LMDP, N= 30) or Nutrition and Physical Activity Information (NPA, N= 30). The LMDP intervention trained families in behavioral strategies to increase parent and child intake of fruits, vegetables, and high fiber foods, to limit intake of energy-dense foods, and to increase daily physical activity. A physical activity "tool kit" for the home environment was provided to families. Supporting information about T2D and obesity, as well as nutrition and physical activity, also were provided. Besides the participating parent-child pair, other adult family members with T2D (eg, grandparents, aunts, uncles) were encouraged to participate. The LMDP activities were intended to reduce children's excess body weight and improve their metabolic and cardiovascular measures, to help prevent the onset of insulin resistance. The NPA intervention only received basic information on T2D and obesity, and nutrition and physical activity recommendations. Changes in child body composition, metabolic and cardiovascular measures, and behavioral outcomes were evaluated at 6 months (ie, end-of-treatment) and 12 months (ie, follow up). Changes in parent weight status and the home food environment were secondary outcomes and were assessed as potential mediators of child outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2, Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Lifestyle Modification for Diabetes Prevention
Arm Type
Active Comparator
Arm Description
Family based intervention utilizing Traffic Light Diet, self monitoring, parent behavioral skill training and tool kit of items promoting physical activity.
Arm Title
Nutrition and Physical Activity
Arm Type
Other
Arm Description
Family based intervention providing education on healthy eating and physical activity but no behavioral skills training, goal setting, self monitoring or physical activity toolkit.
Intervention Type
Behavioral
Intervention Name(s)
Lifestyle Modification for Type 2 Diabetes Prevention
Intervention Description
Family based behavioral intervention utilizing Traffic Light Diet, self monitoring, goal setting, reinforcement and a tool kit containing physical activity-promoting items
Intervention Type
Other
Intervention Name(s)
Nutrition and Physical Activity
Intervention Description
This family based education program provided information on physical activity and healthy eating for parents and children.
Primary Outcome Measure Information:
Title
Body Mass Index (BMI)
Description
Change in BMI will be measured from baseline to end of intervention (6 months) and and also from 6 months to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
BMI-z score
Description
Change in BMI-z score will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Percent overweight (% overweight)
Description
Change in percent overweight will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months. Percent overweight is computed as a child's actual BMI minus the median BMI for a child of comparable sex and age, divided by 100.
Time Frame
Baseline, 6 and 12 months
Title
Waist Circumference(cm)
Description
Change in waist circumference (cm) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Systolic Blood Pressure
Description
Change in systolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Diastolic Blood Pressure (mm Hg)
Description
Change in diastolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Pulse
Description
Change in resting pulse will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Physical Activity
Description
Change in physical activity was measured from baseline to end of treatment (6 months) and from end of treatment to 12 months using an accelerometer. The accelerometer measured light, moderate and moderate-to-vigorous actity over 7 days.
Time Frame
Baseline, 6 and 12 months
Title
Glucose
Description
Change in blood glucose levels were measured at baseline, 6 and 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Insulin
Description
Change in plasma insulin levels from baseline to end of treatment (6 months) and from 6 months to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Change in HDL, LDL, Total Cholesterol and Triglycerides
Description
Change in lipid profile measures from baseline to end of treatment (6 months) and from 6 months to 12 months.
Time Frame
Baseline, 6 and 12 months
Title
Change in Dietary Intake
Description
Change in energy (kcals/day), protein, carbohydrate, fat, cholesterol, saturated fat and fiber intake.
Time Frame
Baseline, 6 and 12 months
Secondary Outcome Measure Information:
Title
Change in Parent BMI
Description
Change in parent BMI from baseline to end of treatment (6 months) and from 6 motnths to 12 months.
Time Frame
Baseline, 6 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 4-8 years old Age- and sex-specific BMI ≥95th percentile Exclusion Criteria: Children with serious medical conditions Children who show signs of elevated psychopathology, as assessed by the Child Behavior Checklist (CBCL) Children of parents with significantly elevated psychiatric disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Myles S Faith, Ph.D.
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Lifestyle Modification for Type 2 Diabetes Prevention in Overweight Youth

We'll reach out to this number within 24 hrs